Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis CRoberta D’Ambrosio, S. Fagiuoli, Monica Schiavini et al.|Journal of Hepatology|2018Cited by 132
Toward the Discovery of Novel Anti‐HIV Drugs. Second‐Generation Inhibitors of the Cellular ATPase DDX3 with Improved Anti‐HIV Activity: Synthesis, Structure–Activity Relationship Analysis, Cytotoxicity Studies, and Target ValidationGiovanni Maga, Maurizio Botta, Federico Falchi et al.|ChemMedChem|2011Cited by 105